📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib (2016)

First Author: Yang G

Attributed to: Characterisation of signal transduction pathways that restrict activation of the innate immune system to prevent inflammatory and autoimmune diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2016-01-695098

PubMed Identifier: 27143257

Publication URI: http://europepmc.org/abstract/MED/27143257

Type: Journal Article/Review

Parent Publication: Blood

Issue: 25

ISSN: 0006-4971